Cellid, COVID-19 vaccine Korean stock
Mis à jour
Bullish
Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Transaction en cours
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts. Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
Transaction en cours
Space elevator~Trade fermée: ordre d’arrêt atteint
Events didn't pan out as I had expected. Too bad.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.